Please login to the form below
irritable bowel syndrome
This page shows the latest irritable bowel syndrome news and features for those working in and with pharma, biotech and healthcare.
Ardelyx gets second kidney disease trial win for tenapanor
verdict on the use of the drug in irritable bowel syndrome.
Latest news
-
China approves Ironwood Pharma’s IBS treatment
Coincides with AZ's Mark Mallon taking over as CEO. Ironwood Pharmaceuticals’ irritable bowel syndrome treatment Linzess has gained approval in China, opening up a market of up to 14m adults ... Approval by China’s NMPA for adults with irritable
-
Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use
pain associated with irritable bowel syndrome (IBSs).
-
NHS could save £7bn with greater diagnostics use
The report specifically evaluated the savings of three existing IVD tests - covering suspected heart attacks, pre-eclampsia in pregnancy and diagnosing irritable bowel syndrome (IBS) - if widely used. ... Lastly, IVDs for common bowel condition IBS could
-
Mallinckrodt pays $1.2bn for Sucampo Pharma
Amitizia is the prize asset in the deal, with FDA approvals in hand for three indications - chronic idiopathic constipation as well as constipation linked to irritable bowel syndrome and chronic opioid
-
NICE backs Allergan's IBS therapy Truberzi
NICE has recommended routine NHS funding for Allergan's Truberzi, which is the first drug for irritable bowel syndrome with diarrhoea (IBS-D) to pass through its review process.
More from news
Approximately 0 fully matching, plus 49 partially matching documents found.
Latest Intelligence
-
Erectile dysfunction, constipation, vaginal dryness and other laughing matters
An Irritable Bowel Syndrome campaign tackled the challenge of IBS not being taken seriously by actually using humour. ... This campaign showed doctors suffering from Irritable Disbelief Syndrome (IDS) - a brave move but exactly the perception shift
-
Taking a lean and careful approach
His pioneering research culminated in the drug, Trulance, which has received FDA approval and is being used to treat irritable bowel syndrome and chronic constipation. ... ulcerative colitis, type 1 diabetes and inflammatory bowel disease.
-
Can biosimilars live up to the hype?
She is convinced that biosimilars are essential in treating patients with chronic conditions such as rheumatoid arthritis, irritable bowel syndrome and psoriasis, because they provide the same uplift in quality of
-
Oral biologics delivery still elusive
years. Among a newer generation of orally-delivered peptides is Ironwood Pharma's peptide drug Linzess/Constella (linaclotide) - which debuted in 2012 for constipation associated with irritable bowel syndrome. ... Among these are Avaxia Biologics, which
-
Pharma deals during April 2014
proteinuria associated with nephrotic syndrome, certain rheumatology-related conditions, and infantile spasms. Whilst this is a 60-year old drug acquired by Questcor in 2001 for $100, 000, generic competition is ... delta opioid receptor antagonist for
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest appointments
-
Ironwood appoints Edward Owens to board
irritable bowel syndrome and constipation.
-
Ironwood promotes Dr Mark Currie
Linaclotide was approved as a treatment for irritable bowel syndrome last year by regulators in Europe, where the drug is marketed as Constella by Almirall.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Diagnosing MS: are we getting it right?
MS symptoms can be hard to pin down. I’ve heard bladder issues being attributed to “women’s problems”, bowel issues to irritable bowel syndrome (IBS), and fatigue to stress and
-
World Ovarian Cancer Day: Current treatments and future hopes for ovarian cancer
Symptoms of ovarian cancer. The symptoms of ovarian cancer are quite similar to those for less serious conditions such as irritable bowel syndrome or pre-menstrual syndrome [3]. ... Other symptoms include persistent indigestion or nausea, a change in
-
Irritable Bowel Syndrome (IBS) patient insights
Irritable Bowel Syndrome: Patient–Provider Interaction and Patient Education. J Clin Med. 2018; 7(1):3. -----. ... Irritable bowel syndrome in adults: diagnosis and management. NICE Clinical Guideline 61; 2017.
-
IGNIFI
Irritable Bowel Syndrome (IBS) patient insights.
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Account Management
-
Competitive Salary Offered
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC
- Saturnino Izquierdo takes on expanded role at McCann Health
- J&J delays EU COVID-19 vaccine rollout following pause in the US
- Moderna’s booster vaccine for South African variant demonstrates promising early results
- UK trial evaluating mixed-vaccine regimens includes two more jabs
- Follow the user – democratising medical conference design
PMHub
Origins Insights
Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...
Latest intelligence
- How a design mindset can lead to better medical outcomes
- By adopting a design philosophy, healthcare companies can develop communications that allow healthcare professionals (HCPs) to better meet the needs of their patients. Imaginatively designed content combined with patient insights...
- How does the government plan to reshape the NHS?
- Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care...
- Want to give perfect client service? Tough luck, you’re human
- In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
Quick links
Infographics
